SAL0140 for hypertension

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Dec 2025: Trial started, NCT07654140
  2. 17 Jun 2026: Trial registered, NCT07654140

The trials

NCT07654140: A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

State
Under way
Phase
Phase 2
People
252 planned
Started
9 Dec 2025
Primary completion
1 Mar 2027
Arms
Low-dose group, Middle-dose group, High-dose group
Results
None posted
  1. 9 Dec 2025: Trial started
  2. 17 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.